The results of a recent study presented at the 2023 Hematology/Oncology Pharmacy Association annual conference suggest health care providers should be vigilant about the overutilization of potentially...
The FDA has approved a treatment for Friedreich ataxia after the results of randomized, placebo-controlled study indicate a strong effectiveness in treatment.
Researchers evaluated the impact an intensified dose of dolutegravir had on patients living with HIV. Their research was presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2023...
Researchers set out to determine the percentage of people in the United States with type 2 diabetes who meet the recommended criteria to use GLP-1 receptor agonists and SGLT-2 inhibitors as well as patients...
In a recent study presented at the Hematology/Oncology Pharmacy Association annual conference, researchers examined the use of opioids in patients with head and neck squamous cell carcinoma while undergoing...
Researchers conducted a trial to investigate the use of cannabidiol (CBD) to help manage pain in patients with psoriatic arthritis and hand osteoarthritis.
The USPSTF has released a reaffirmation of their recommendations for screening for genital herpes infection in adolescents, adults, and pregnant persons.
Researchers performed a retrospective, single-center, observational cohort study to evaluate the safety outcomes of standard vs rapid infusion rates in patients who received oxaliplatin.
Among those with statin-intolerance, bempedoic acid, an inhibitor used to decrease elevated levels of low-density lipoprotein cholesterol, was also associated with a lower risk of major adverse...
The updates and recommendations by the CDC and several organizations include the addition of the COVID-19 vaccine for pediatric patients and a new pneumococcal conjugate vaccine.
